taurine has been researched along with Multiple Myeloma in 2 studies
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yin, Q | 1 |
| Shen, X | 1 |
| Xu, H | 1 |
| Feng, W | 1 |
| Shi, X | 1 |
| Ju, S | 1 |
| Láng, I | 1 |
| Feuer, L | 1 |
| Nèkám, K | 1 |
| Török, K | 1 |
| Kalmár, L | 1 |
| Gergely, P | 1 |
2 other studies available for taurine and Multiple Myeloma
| Article | Year |
|---|---|
YY1-induced LncRNA-TUG1 elevates YOD1 to promote cell proliferation and inhibit bortezomib sensitivity in multiple myeloma.
Topics: Apoptosis; Bortezomib; Cell Line, Tumor; Cell Proliferation; Endopeptidases; Gene Expression Regulat | 2023 |
Effect of treatment with glutaurine on human antibody-dependent cell-mediated cytotoxicity (ADCC).
Topics: Adult; Aged; Animals; Antibody-Dependent Cell Cytotoxicity; Breast Neoplasms; Colonic Neoplasms; Fem | 1981 |